Untargeted metabolomics reveal signatures of a healthy lifestyle
Wishart, D. S. et al. HMDB 5.0: The Human Metabolome Database for 2022. Nucleic Acids Res. 50, D622–D631 (2022).
Google Scholar
Babu, M. & Snyder, M. Multi-omics profiling for health. Mol. Cell Proteomics 22, 100561 (2023).
Google Scholar
Li, Y. et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: Prospective cohort study. BMJ 368, l6669 (2020).
Google Scholar
Li, Y. et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation 138, 345–355 (2018).
Google Scholar
Nyberg, S. T. et al. Association of healthy lifestyle with years lived without major chronic diseases. JAMA Intern. Med. 180, 760–768 (2020).
Google Scholar
Carrard, J. et al. The metabolic signature of cardiorespiratory fitness: A systematic review. Sports Med. 52, 527–546 (2022).
Google Scholar
Castro, A. et al. Understanding the relationship between intrinsic cardiorespiratory fitness and serum and skeletal muscle metabolomics profile. J. Proteome Res. 20, 2397–2409 (2021).
Google Scholar
Contrepois, K. et al. Molecular choreography of acute exercise. Cell 181, 1112-1130.e16 (2020).
Google Scholar
Kistner, S. et al. Sex-specific relationship between the cardiorespiratory fitness and plasma metabolite patterns in healthy humans-results of the KarMeN study. Metabolites 11, 463 (2021).
Google Scholar
Weiss, A. et al. Sustained endurance training leads to metabolomic adaptation. Metabolites 12, 658 (2022).
Google Scholar
Noerman, S. & Landberg, R. Blood metabolite profiles linking dietary patterns with health-toward precision nutrition. J. Intern. Med. 293, 408–432 (2023).
Google Scholar
Lépine, G. et al. A scoping review: Metabolomics signatures associated with animal and plant protein intake and their potential relation with cardiometabolic risk. Adv. Nutr. 12, 2112–2131 (2021).
Google Scholar
Rafiq, T. et al. Nutritional metabolomics and the classification of dietary biomarker candidates: A critical review. Adv. Nutr. 12, 2333–2357 (2021).
Google Scholar
Andraos, S. et al. Characterizing patterns of dietary exposure using metabolomic profiles of human biospecimens: A systematic review. Nutr. Rev. 80, 699–708 (2022).
Google Scholar
Kim, H. & Rebholz, C. M. Metabolomic biomarkers of healthy dietary patterns and cardiovascular outcomes. Curr. Atheroscler. Rep. 23, 26 (2021).
Google Scholar
LeVatte, M., Keshteli, A. H., Zarei, P. & Wishart, D. S. Applications of metabolomics to precision nutrition. Lifestyle Genom. 15, 1–9 (2022).
Google Scholar
Giesbertz, P. et al. Age-related metabolite profiles and their relation to clinical outcomes in young adults, middle-aged individuals, and older people. FASEB J. 37, e22968 (2023).
Google Scholar
Cirulli, E. T. et al. Profound perturbation of the metabolome in obesity is associated with health risk. Cell Metab. 29, 488-500.e2 (2019).
Google Scholar
Auguet, T. et al. LC/MS-based untargeted metabolomics analysis in women with morbid obesity and associated type 2 diabetes mellitus. Int. J. Mol. Sci. 24, 7761 (2023).
Google Scholar
Ho, J. E. et al. Metabolomic profiles of body mass index in the Framingham heart study reveal distinct cardiometabolic phenotypes. PLoS ONE 11, e0148361 (2016).
Google Scholar
Watanabe, K. et al. Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention. Nat. Med. 29, 996–1008 (2023).
Google Scholar
Carayol, M. et al. Blood metabolic signatures of body mass index: A targeted metabolomics study in the EPIC cohort. J. Proteome Res. 16, 3137–3146 (2017).
Google Scholar
Bellot, P. E. N. R. et al. are phosphatidylcholine and lysophosphatidylcholine body levels potentially reliable biomarkers in obesity? A review of human studies. Mol. Nutr. Food Res. 67, e2200568 (2023).
Google Scholar
Navarro, S. L. et al. Demographic, health and lifestyle factors associated with the metabolome in older women. Metabolites 13, 514 (2023).
Google Scholar
Lu, Q. et al. Healthy lifestyle, plasma metabolites, and risk of cardiovascular disease among individuals with diabetes. Atherosclerosis 367, 48–55 (2023).
Google Scholar
Kaspy, M. S. et al. Metabolomic profile of combined healthy lifestyle behaviours in humans: A systematic review. Proteomics 22, e2100388 (2022).
Google Scholar
Palau-Rodriguez, M. et al. Effects of a long-term lifestyle intervention on metabolically healthy women with obesity: Metabolite profiles according to weight loss response. Clin. Nutr. 39, 215–224 (2020).
Google Scholar
Dunn, W. B. et al. Systems level studies of mammalian metabolomes: The roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem. Soc. Rev. 40, 387–426 (2011).
Google Scholar
Wishart, D. S. Metabolomics for investigating physiological and pathophysiological processes. Physiol. Rev. 99, 1819–1875 (2019).
Google Scholar
Nieman, D. C. et al. Healthy lifestyle linked to innate immunity and lipoprotein metabolism: A cross-sectional comparison using untargeted proteomics. Sci. Rep. 13, 16728 (2023).
Google Scholar
Li, Y.-Y. et al. Untargeted metabolomics: Biochemical perturbations in Golestan cohort study opium users inform intervention strategies. Front. Nutr. 7, 584585 (2020).
Google Scholar
Ghanbari, R. et al. Metabolomics reveals biomarkers of opioid use disorder. Transl. Psychiatry 11, 103 (2021).
Google Scholar
Lynch, D. H. et al. Baseline serum biomarkers predict response to a weight loss intervention in older adults with obesity: A pilot study. Metabolites 13, 853 (2023).
Google Scholar
Sun, J. & Xia, Y. Pretreating and normalizing metabolomics data for statistical analysis. Genes Dis. 11(3), 100979. (2023).
Google Scholar
Chan, E. C., Pasikanti, K. K. & Nicholson, J. K. Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nat. Protoc. 6(10), 1483–1499. (2011).
Google Scholar
Välikangas, T., Suomi, T. & Elo, L. L. A systematic evaluation of normalization methods in quantitative label-free proteomics. Brief Bioinform. 19, 1–11 (2018).
Google Scholar
Smirnov, A. et al. ADAP-KDB: A spectral knowledgebase for tracking and prioritizing unknown GC-MS spectra in the NIH’s metabolomics data repository. Anal. Chem. 93, 12213–12220 (2021).
Google Scholar
Bylesjö, M. et al. OPLS discriminant analysis: Combining the strengths of PLS-DA and SIMCA classification. J. Chemom. 20, 341–351 (2006).
Google Scholar
Eriksson, L. et al. Multi- and Megavariate Data Analysis Basic Principles and Applications (Umetrics Academy, 2013).
Broadhurst, D. et al. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics 14, 72 (2018).
Google Scholar
Rothman, K. J. No adjustments are needed for multiple comparisons. Epidemiology 1, 43–46 (1990).
Google Scholar
Bender, R. & Lange, S. Adjusting for multiple testing—When and how?. J. Clin. Epidemiol. 54, 343–349 (2001).
Google Scholar
Xi, D. & Tamhane, A. C. A general multistage procedure for k-out-of-n gatekeeping. Stat. Med. 33, 1321–1335 (2014).
Google Scholar
Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1–22 (2010).
Google Scholar
Tay, J. K., Narasimhan, B. & Hastie, T. Elastic net regularization paths for all generalized linear models. J. Stat. Softw. 106, 1 (2023).
Google Scholar
Li, S. et al. Predicting network activity from high throughput metabolomics. PLoS Comput. Biol. 9, e1003123 (2013).
Google Scholar
Chong, J., Wishart, D. S. & Xia, J. Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr. Protoc. Bioinformatics 68, e86 (2019).
Google Scholar
Pang, Z. et al. MetaboAnalyst 5.0: Narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 49, W388–W396 (2021).
Google Scholar
Pang, Z. et al. Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat. Protoc. 17, 1735–1761 (2022).
Google Scholar
Qi, L. & Chen, Y. Circulating bile acids as biomarkers for disease diagnosis and prevention. J. Clin. Endocrinol. Metab. 108, 251–270 (2023).
Google Scholar
Haeusler, R. A. et al. Increased bile acid synthesis and impaired bile acid transport in human obesity. J. Clin. Endocrinol. Metab. 101, 1935–1944 (2016).
Google Scholar
Osuna-Prieto, F. J. et al. Plasma levels of bile acids are related to cardiometabolic risk factors in young adults. J. Clin. Endocrinol. Metab. 107, 715–723 (2022).
Google Scholar
Mercer, K. E. et al. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women. Am. J. Physiol. Endocrinol. Metab. 320, E864–E873 (2021).
Google Scholar
Maurer, A. et al. Divergence in aerobic capacity impacts bile acid metabolism in young women. J. Appl. Physiol. 1985(129), 768–778 (2020).
Google Scholar
Tveter, K. M., Mezhibovsky, E., Wu, Y. & Roopchand, D. E. Bile acid metabolism and signaling: Emerging pharmacological targets of dietary polyphenols. Pharmacol. Ther. 248, 108457 (2023).
Google Scholar
Byrd, D. A. et al. An investigation of cross-sectional associations of a priori-selected dietary components with circulating bile acids. Am. J. Clin. Nutr. 114, 1802–1813 (2021).
Google Scholar
Kelly, R. S., Kelly, M. P. & Kelly, P. Metabolomics, physical activity, exercise and health: A review of the current evidence. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165936 (2020).
Google Scholar
Niu, Y.-C. et al. Histidine and arginine are associated with inflammation and oxidative stress in obese women. Br. J. Nutr. 108, 57–61 (2012).
Google Scholar
Maltais-Payette, I. et al. Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations. Nutr. Metab. 15, 78 (2018).
Google Scholar
DiNicolantonio, J. J., McCarty, M. F. & OKeefe, J. H. Role of dietary histidine in the prevention of obesity and metabolic syndrome. Open Heart 5, e000676 (2018).
Google Scholar
Quesada-Vázquez, S. et al. Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesity. Cell Rep. Med. 4, 101341 (2023).
Google Scholar
Yao, H., Li, K., Wei, J., Lin, Y. & Liu, Y. The contradictory role of branched-chain amino acids in lifespan and insulin resistance. Front. Nutr. 10, 1189982 (2023).
Google Scholar
Driuchina, A. et al. Identification of gut microbial lysine and histidine degradation and cyp-dependent metabolites as biomarkers of fatty liver disease. mBio 14, e0266322 (2023).
Google Scholar
Maas, M. N., Hintzen, J. C. J., Porzberg, M. R. B. & Mecinović, J. Trimethyllysine: From carnitine biosynthesis to epigenetics. Int. J. Mol. Sci. 21, 9451 (2020).
Google Scholar
Zhang, X. et al. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. EBioMedicine 98, 104873 (2023).
Google Scholar
Wang, C. et al. Pipecolic acid confers systemic immunity by regulating free radicals. Sci. Adv. 4, eaar4509 (2018).
Google Scholar
Deng, Y. et al. An adipo-biliary-uridine axis that regulates energy homeostasis. Science 355, eaaf5375 (2017).
Google Scholar
Kim, M. J. et al. Metabolomics associated with genome-wide association study related to the basal metabolic rate in overweight/obese Korean women. J. Med. Food 22, 499–507 (2019).
Google Scholar
Liu, Y. et al. Uridine attenuates obesity, ameliorates hepatic lipid accumulation and modifies the gut microbiota composition in mice fed with a high-fat diet. Food Funct. 12, 1829–1840 (2021).
Google Scholar
He, M. et al. Causal relationship between human blood metabolites and risk of ischemic stroke: A Mendelian randomization study. Front. Genet. 15, 1333454 (2024).
Google Scholar
Jiang, N. & Zhao, Z. Intestinal aging is alleviated by uridine via regulating inflammation and oxidative stress in vivo and in vitro. Cell Cycle 21, 1519–1531 (2022).
Google Scholar
Abiri, B. et al. Association of vitamin D levels with anthropometric and adiposity indicators across all age groups: A systematic review of epidemiologic studies. Endocr. Connect. 13, e230394 (2024).
Google Scholar
Vranić, L., Mikolašević, I. & Milić, S. Vitamin D deficiency: Consequence or cause of obesity?. Medicina 55, 541 (2019).
Google Scholar
Park, J. E., Pichiah, P. B. T. & Cha, Y.-S. Vitamin D and metabolic diseases: Growing roles of vitamin D. J. Obes. Metab. Syndr. 27, 223–232 (2018).
Google Scholar
Wamberg, L., Pedersen, S. B., Rejnmark, L. & Richelsen, B. Causes of vitamin D deficiency and effect of vitamin D supplementation on metabolic complications in obesity: A review. Curr. Obes. Rep. 4, 429–440 (2015).
Google Scholar
Deriš, H. et al. Susceptibility of human plasma N-glycome to low-calorie and different weight-maintenance diets. Int. J. Mol. Sci. 23, 15772 (2022).
Google Scholar
Greto, V. L. et al. Extensive weight loss reduces glycan age by altering IgG N-glycosylation. Int. J. Obes. 45, 1521–1531 (2021).
Google Scholar
Noel, M. et al. the inflammation biomarker GlycA reflects plasma N-Glycan branching. Clin. Chem. 69, 80–87 (2023).
Google Scholar
Zhang, L. et al. Functional metabolomics characterizes a key role for N-Acetylneuraminic acid in coronary artery diseases. Circulation 137, 1374–1390 (2018).
Google Scholar
Ferrannini, E. et al. Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man. Metabolism 102, 153974 (2020).
Google Scholar
Mardinoglu, A. et al. Plasma mannose levels are associated with incident type 2 diabetes and cardiovascular disease. Cell Metab. 26, 281–283 (2017).
Google Scholar
Yamauchi, M. et al. Urinary level of l-fucose as a marker of alcoholic liver disease. Alcohol Clin. Exp. Res. 17, 268–271 (1993).
Google Scholar
Sakai, T. et al. Rapid, simple enzymatic assay of free l-fucose in serum and urine, and its use as a marker for cancer, cirrhosis, and gastric ulcers. Clin. Chem. 36, 474–476 (1990).
Google Scholar
Htun, K. T. et al. Identification of metabolic phenotypes in young adults with obesity by 1H NMR metabolomics of blood serum. Life 11, 574 (2021).
Google Scholar
Rios, S. et al. Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes. Cardiovasc. Diabetol. 22, 252 (2023).
Google Scholar
Wei, Y.-H., Ma, X., Zhao, J.-C., Wang, X.-Q. & Gao, C.-Q. Succinate metabolism and its regulation of host–microbe interactions. Gut Microbes 15, 2190300 (2023).
Google Scholar
Lee, Y.-M., Shin, J.-Y., Kim, S.-A., Jacobs, D. R. & Lee, D.-H. Can habitual exercise help reduce serum concentrations of lipophilic chemical mixtures? Association between physical activity and persistent organic pollutants. Diabetes Metab. J. 44, 764–774 (2020).
Google Scholar
Pelletier, C., Després, J.-P. & Tremblay, A. Plasma organochlorine concentrations in endurance athletes and obese individuals. Med. Sci. Sports Exerc. 34, 1971–1975 (2002).
Google Scholar
Huang, Y. & Fang, M. Nutritional and environmental contaminant exposure: A tale of two co-existing factors for disease risks. Environ. Sci. Technol. 54, 14793–14796 (2020).
Google Scholar
Jujić, A. et al. Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects. Sci. Rep. 11, 20246 (2021).
Google Scholar
Lapenna, D. Glutathione and glutathione-dependent enzymes: From biochemistry to gerontology and successful aging. Ageing Res. Rev. 92, 102066 (2023).
Google Scholar
Singh, Y. P. & Kumar, H. Tryptamine: A privileged scaffold for the management of Alzheimer’s disease. Drug Dev. Res. 84, 1578–1594 (2023).
Google Scholar
Alvarenga, L., Ferreira, M. S., Kemp, J. A. & Mafra, D. The role of betaine in patients with chronic kidney disease: A narrative review. Curr. Nutr. Rep. 11, 395–406 (2022).
Google Scholar
Palmnäs, M. et al. Perspective: Metabotyping—a potential personalized nutrition strategy for precision prevention of cardiometabolic disease. Adv. Nutr. 11, 524–532 (2020).
Google Scholar
link